Researchers from the company Synchron managed to get the United States Food and Drug Administration to allow them to start clinical trials in patients with ALS. It focused on the accessibility of these patients to electronic devices (tablets and cell phones) that can be managed with the mind.
The company-designed invention requires the use of a brain implant that is linked to a device called a Synchron Switch that is placed on the patient’s chest. Through this, it sends messages to devices such as smartphones and tablets without touch interaction with the device.
Also read: Why you don’t have to use unlock patterns on your mobile phone
During the tests, the participants did not experience any inconvenience. From Synchron they define this system as a “Bluetooth for the brain”. Meanwhile, Tom Oxley, executive director of the firm, said that there is great interest in the advance being used with widely used devices, and commented that there are still a few years of research and development to make the process really smooth.